Advances in research of Apo C-Ⅲ and Coronary Atherosclerosis Heart Disease
YU Jin-jin1
ZHU Ping2
PAN Wei3
1.Department of Cardiac Surgery,Guangdong Cardio-vascular Institute,Guangdong Provincial People's Hospital,Guangdong Academy of Medical Sciences;Department of Pe-diatric Cardiology,Guangdong Cardiovascular Institute,Guang-dong Provincial People's Hospital,Guangdong Academy of Medical Sciences2.Department of Cardiac Surgery,Guangdong Cardio-vascular Institute,Guangdong Provincial People's Hospital,Guangdong Academy of Medical Sciences3.Department of Cardiac Surgery,Guangdong Cardio-vascular Institute,Guangdong Provincial People's Hospital,Guangdong Academy of Medical Sciences;Department of Maternal-Fetal Cardiology,Guangdong Cardiovascular Institute,Guangdong Provincial People's Hospital,Guangdong Academy of Medical Sciences
摘要：Coronary atherosclerotic heart disease had been regarded as the leading killer of human being.The atherosclerotic lesion would cause blood flow blockage or lumen stenosis of coronary arteries,thus resulting in myocardial ischemic or sudden cardiac death.Though exact causes of coronary atherosclerosis heart disease is not known,the promising Apo C-Ⅲ that played a crucial role in metabolism of triglyceride-rich lipoproteins had been supposed to be one of the key factor of pathogenesis.In this review,we discuss roles of Apo C-Ⅲ in the develop-ment of CAD and its insights being a new therapeutic target.
机标关键词：researchheartadvancesatherosclerosiscoronarydisease
论文发表日期：2022-06-30
在线出版日期：2025-08-15（本平台首次上网日期，不代表文献的发表时间）
页数：8( 103-110 )
英文信息